483 DermAvance Pharmaceuticals Jul 2018

483 DermAvance Pharmaceuticals Jul 2018

Joseph Despins FDA$119.00 - Available Now

FDA investigators audited the DermAvance Pharmaceuticals - Malvern, PA, United States facility and issued inspectional observations (via FDA 483) on 17 Jul 2018.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 17 Jul 2018
  • Location: Malvern, United States
  • FEI: 3005881732
Add To Cart